ERBLAN Surgical designs and develops medical devices that produce breakthrough advances for minimally invasive surgery (MIS) safety. Opportunities exist within the billion-dollar minimally invasive surgery (MIS) device market to introduce “disruptive technology” that offers a greater degree of safety with a reduction in risks, liability and injury. We have early-stage license opportunities with a number of our patented and patent-pending device improvements.

In today’s market there are “shielded,” “bladeless,” and “optical” trocars – none have yet to reduce injury rates significantly. Newer trocars have not appreciably decreased the incidence of complications, significantly reduced mortality rates, nor reduced liability costs. We believe there is a better way.

We have designed an innovative Trocar that is superior to models currently available. Our design ensures a blade is never exposed to internal organs, uses low penetration force, and its flat blade is less damaging than pyramidal or shredding "bladeless" tips. Our simplicity of design enhances reliability, reduces the cost to manufacture and requires fewer parts than existing trocars. Our patented Trocar is now available for investors to license and manufacture.

In addition to our Trocar, we also have designed a safer Insufflator Needle. Like the Trocar, our Insufflator Needle is state-of-the-art and superior to Veress needles currently used today. Our patent-pending Insufflator Needle is now available for investors to license and manufacture. This needle will also find uses for gaining access to delicate spaces throughout the body for the removal of fluids, or the administration of medications.

Within trocars are gas seals. Our Universal Gas Seal represents a truly innovative approach when compared to currently available designs. The one-piece element is reliable, simple to manufacture and offers increased effectiveness. Our patented Universal Gas Seal is available for investors to license and manufacture.

Patients, Surgeons, Hospitals, Clinics and Insurance Companies will all benefit from our offerings. If you would like more information about the opportunities available from our intellectual property portfolio, please contact us.